Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.
Lin Z, Chen YY, Liu CH, Panzuto F, Ramirez RA, Lang M, Kim H, Ding ZY. Lin Z, et al. Among authors: ding zy. J Gastrointest Oncol. 2023 Dec 31;14(6):2309-2323. doi: 10.21037/jgo-23-905. Epub 2023 Dec 22. J Gastrointest Oncol. 2023. PMID: 38196527 Free PMC article.
Case Report: Successful conversion and salvage resection of huge hepatocellular carcinoma with portal vein tumor thrombosis and intrahepatic metastasis via sequential hepatic arterial infusion chemotherapy, lenvatinib plus PD-1 antibody followed by simultaneous transcatheter arterial chemoembolization, and portal vein embolization.
Luo X, Chang RZ, Kuang D, Yuan M, Li GX, Zhang B, Wang YJ, Zhang WG, Ding ZY. Luo X, et al. Among authors: ding zy. Front Immunol. 2023 Oct 18;14:1285296. doi: 10.3389/fimmu.2023.1285296. eCollection 2023. Front Immunol. 2023. PMID: 37928536 Free PMC article.
Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodies.
Gao H, Chang RZ, Chen XP, Zhang WG, Zhang B, Luo X, Ding ZY. Gao H, et al. Among authors: ding zy. Front Immunol. 2023 Oct 6;14:1274449. doi: 10.3389/fimmu.2023.1274449. eCollection 2023. Front Immunol. 2023. PMID: 37869012 Free PMC article.
225 results